At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how taxation frameworks and market surveillance systems are shaping the regulation and development of alternative nicotine products across the EU and beyond. The session was moderated by Ciprian Boboi and featured contributions from Tomasz PĹ‚aska, Leonhard Kipphan, and Lorenzo…
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a panel session exploring the factors influencing consumer adoption of new nicotine products, focusing on innovation, accessibility, and regulatory context. The session was moderated by Marc Reisner and featured contributions from Waqas Khan, Vincent Reid, and John Dunne, offering perspectives from manufacturing, distribution, and…
At EVO NXT 2026, the Global Institute for Novel Nicotine opened its programme with a panel session examining the latest scientific evidence, regulatory frameworks, and public health considerations surrounding tobacco harm reduction. The session was moderated by Philipp Markl and featured contributions from Dr Sydney Hiller, Sairah Salim-Sartoni, and John Dunne, bringing together perspectives from…
EVO NXT 2026 officially opened on April 17, 2026, at Forum KarlĂn in Prague, bringing together stakeholders from across the next-generation products (NGP) sector, including manufacturers, regulators, researchers, and public health representatives. Positioned as a business-focused event, EVO NXT serves as a platform for examining how innovation, regulation, and market developments are shaping the future…
Over the last decade, smoking has fallen across most high-income countries, but not at the same pace. In some jurisdictions, the decline has been steep; in others, more gradual and persistent. This variation is not solely explained by cultural or economic factors. It reflects differences in regulatory design and how policymakers approach nicotine use. This…
The nicotine pouch category is evolving rapidly across global markets, driven by regulatory shifts, growing consumer adoption, and strategic investment from major industry players. At GINN, we are building an AI-powered monitoring system designed to track global nicotine and oral product developments with greater speed, accuracy, and relevance. The concept is simple: AI scans hundreds…
Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single regulatory category. The emphasis is shifting from differentiated risk communication to a comprehensive, product‑agnostic ban on advertising, promotion, and sponsorship. đź“‘ Key Shifts in Policy…
The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products. 🔍 Framing & Methodology • Smoking prevalence reduction is treated as the main success metric, yet the evaluation does not convincingly isolate the TPD’s impact…
Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New Zealand highlights how differing policy approaches toward nicotine products are associated with divergent trends in smoking prevalence. Both countries have implemented strong tobacco control measures…
Ireland’s upcoming Presidency of the Council of the European Union presents a strategic opportunity to shape Europe’s public health agenda at a time of growing pressure on health systems and widening inequalities in outcomes. Recent discussions highlight a clear direction: stronger coordination, a renewed focus on prevention, and the need to address high-burden diseases through…
New U.S. evidence highlights patterns relevant to harm reduction policy As nicotine pouches (ONPs) continue to expand in the United States, understanding how adult smokers engage with these products is becoming increasingly important for evidence-based regulation. A recent peer-reviewed study using nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study provides…
A productive and timely discussion in Vilnius with a European Parliament delegation led by Auke Zijlstra, MEP & Sebastian Kruis, MEP, Wilson George Group, NOIS Nicotine Pouches, Johan Nissinen, Glick®, Chubby Gorilla®, Inc., Adam Gambrill,Tautvydas Kviliunas and Andrius Miskelevicius on the evolving regulatory landscape for nicotine pouches across the Baltics and Europe. At the recent…
Across the European Union, tobacco control policy has historically focused on reducing smoking through restrictions, taxation, and public health campaigns. These measures have contributed to steady declines in smoking prevalence over time. However, the pace of change has varied across Member States, and smoking remains a significant public health concern. Within this broader context, Sweden…
European Union regulatory frameworks are designed to provide stability, predictability, and coherence across Member States. Directives such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED) are central to this approach, establishing the rules that govern how tobacco and nicotine products are regulated and taxed across the internal market. These frameworks are…
Debates on tobacco and nicotine policy within the European Union have often been characterised by strong views and high levels of engagement. This reflects the importance of the issue. Tobacco use remains a leading cause of preventable disease, and decisions taken by policymakers have long-term implications for public health across Member States. However, the intensity…
Across the European Union, tobacco control policy has long focused on reducing smoking prevalence through a combination of regulatory restrictions, public health campaigns, and excise taxation. These approaches have contributed to meaningful progress over time. However, smoking remains a leading cause of preventable disease, and reducing its impact continues to be a central objective of…
European tobacco and nicotine policy is shaped by several regulatory instruments. Among the most important are the Tobacco Products Directive (TPD), which establishes product standards and regulatory requirements, and the Tobacco Excise Directive (TED), which governs how tobacco products are taxed across the European Union. Although these two frameworks address different aspects of regulation, their…
Public health policy often develops through long institutional processes. Regulations are debated, negotiated, and revised through multiple stages of consultation and political review. This is particularly true in the European Union, where legislative frameworks such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED) shape tobacco and nicotine policy across all Member…
The revision of the European Union’s Tobacco Excise Directive (TED) presents an important moment for policymakers to reconsider how taxation influences tobacco and nicotine use across Member States. While excise policy is often described as a technical fiscal instrument, its impact extends far beyond government revenue. Tax policy directly shapes consumer behaviour, market dynamics, and…
The European Union’s Tobacco Products Directive (TPD) is entering another period of review. These revisions are not frequent. When they occur, they shape the regulatory environment for many years to come, influencing product standards, market access, and public health policy across all Member States. For those who have worked on EU policy files, the significance…
Debates around nicotine policy often focus narrowly on dependence and youth protection. Far less frequently examined, but increasingly discussed in scientific and policy literature, is nicotine’s relationship with cognition and mental health. Emerging research suggests that nicotine may have measurable short-term effects on attention, working memory, and executive function. At the same time, long-standing concerns…
Excise taxation is one of the most powerful tools in tobacco control. Price signals influence initiation, continuation, cessation, and product switching. As nicotine markets diversify beyond combustible cigarettes, the question facing policymakers is no longer simply whether to tax nicotine products, but how to structure taxation in a way that aligns with relative risk and…
Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC) has become one of the most frequently cited provisions in contemporary nicotine policy debates. The clause is concise: “In setting and implementing their public health policies with respect to tobacco control, Parties shall act to protect these policies from commercial and other vested interests…
From April 2026, Austria will implement its first fully defined national regulatory framework for nicotine pouches. The reform moves the category from a fragmented legal grey zone into a structured regime anchored in tobacco legislation, combining legal availability with strict controls on youth access, sales channels, product standards, and taxation. The shift is not a…
Brazil is widely recognised for achieving one of the most significant declines in smoking prevalence globally over the past three decades. Comprehensive tobacco control measures, including advertising restrictions, smoke-free laws, warning labels, taxation, and cessation support, have contributed to sustained reductions in cigarette consumption and tobacco-related disease. At the same time, Brazil maintains one of…
The latest compromise text under the Cypriot Presidency in the revision of the EU Tobacco Taxation Directive represents a cautious but meaningful shift in the debate over nicotine pouch excise. While the proposal does not fully resolve concerns around proportionality and risk alignment, it acknowledges a central empirical reality: national taxation of nicotine pouches varies…
Public debate around tobacco harm reduction (THR) is increasingly shaped not only by science, but by how that science is communicated. As non-combustible nicotine products expand across global markets, the gap between evidence and public understanding has become a central policy challenge. Miscommunication, oversimplification, and emotive framing risk distorting regulatory discussions at precisely the moment…
As nicotine pouches gain market presence in the United States, regulators must understand not only who is using these products, but where and under what conditions they are being purchased. A recent peer-reviewed study published in Preventive Medicine provides new empirical evidence by examining urban–rural differences in nicotine pouch sales, pricing, and flavour preferences across…
Recent market analyses from multiple industry research groups indicate that nicotine pouches are among the fastest-growing segments within the broader nicotine alternatives category. Reports from Fact.MR, Euromonitor International, Grand View Research, and other sector analysts project sustained global expansion over the coming decade, driven by regulatory pressure on combustible cigarettes, product innovation, and widening consumer…
Debates around tobacco harm reduction are increasingly shaped not only by emerging products and regulatory decisions, but by how science itself is communicated. A recent commentary on misinformation and “clickbait science” in the tobacco harm reduction space highlights a growing concern: that exaggerated claims, selective interpretation of findings, and sensational headlines can distort both public…
The U.S. Food and Drug Administration’s ongoing review of modified risk tobacco product (MRTP) applications for ZYN nicotine pouches represents a pivotal moment in the regulation of non-combustible nicotine. At stake is not whether nicotine products are “safe,” but whether regulators will permit carefully constrained, evidence-based communication about relative risk compared with cigarette smoking. The…
Nicotine pouches remain at the centre of the global harm‑reduction conversation — and a major new peer‑reviewed review helps explain why. A new narrative review by Konstantinos Farsalinos in Internal and Emergency Medicine reinforces a clear message: modern, tobacco‑free nicotine pouches sit at the very lowest end of the toxicant‑exposure continuum. Chemical analyses and biomarker…
Nicotine policy is increasingly being shaped not only by legislators and regulators, but by the channels through which products are made available to adults. In several countries, pharmacies have emerged as a focal point in this debate, acting either as formal gatekeepers of access or as trusted retail environments for smoke-free nicotine products. How pharmacists…
The European Commission has confirmed that the EU Tobacco Policy Expert Group (TPEG) will formally conclude its mandate, even as work on the next revision of the Tobacco Products Directive (TPD) continues. While the end of a technical advisory body may appear procedural, it raises important questions about how expertise, evidence, and stakeholder input will…
As nicotine pouches continue to attract regulatory attention, discussion has increasingly focused on isolated clinical observations and precautionary warnings, often without sufficient context on real-world use patterns or comparative risk. This imbalance risks obscuring a more important question for public health: how nicotine pouches are actually used, by whom, and how regulation can address legitimate…
Nicotine pouches continue to expand across multiple markets, even as regulatory scrutiny intensifies and public debate grows more polarised. This sustained growth is not accidental, nor is it driven by novelty alone. It reflects a convergence of behavioural, commercial, and policy dynamics that are reshaping how adult nicotine users move away from combustible cigarettes. For…
A GINN Insight responding to recent Medscape coverage Nicotine pouches are increasingly positioned at the centre of a familiar policy tension: how to protect young people from nicotine initiation without undermining harm-reduction pathways for adults who smoke. Recent media coverage, including a Medscape Medical News feature, rightly raises youth-protection concerns but risks misrepresenting the evidence…
Nicotine pouches are no longer a niche or experimental category. Retail and market indicators now show sustained growth across major U.S. convenience channels, reinforcing a reality that regulators globally can no longer ignore: consumer uptake is happening faster than policy alignment. Recent U.S. retail reporting highlights accelerating sales, expanding shelf presence, and increasing manufacturer investment…
As nicotine pouches gain visibility in multiple markets, debate around their public-health role is intensifying. A recent peer-reviewed study published in JAMA Network Open adds important empirical clarity to that discussion, particularly around who is using nicotine pouches, why they are using them, and what this means for smoking-related harm. Rather than focusing on speculative…
Nicotine pouches are increasingly discussed as a distinct category within the broader harm-reduction landscape, raising important questions about how they should be regulated, communicated, and positioned relative to smoking cessation tools. A recent commentary in The Lancet Public Health provides a timely and balanced lens through which to assess these questions, particularly as policy debates…
As nicotine pouches continue to attract regulatory attention, a recurring challenge for policymakers is separating assumptions from evidence. Much of the debate has focused on hypothetical risks, youth narratives, or product novelty, while comparatively less attention has been paid to how adult users actually perceive and use these products in real-world contexts. A recent peer-reviewed…
Following GINN’s recent market‑insights visit to Lebanon, led by our Director Shem Baldeosingh, we continue to learn from frontline experts who see the realities of nicotine use, smoking, and harm reduction every day. This week, Dr Vera Matta (@dr.veramatta), a respected clinician and public health communicator, highlighted an important point while reviewing REBEL White Slim…
As nicotine pouches continue to expand across multiple markets, questions about who uses them, why they are used, and how they fit into tobacco control strategies are becoming increasingly important. A recent peer-reviewed article published by Springer adds to this evidence base by examining patterns of nicotine pouch use and their implications for public health…
In recent months, Argentina has emerged as an unexpected focal point in the global debate over nicotine pouches, harm reduction, and regulatory coherence. As international brands begin to enter the market and attract consumer attention, provincial authorities have moved quickly to restrict nicotine pouches using existing tobacco-control frameworks. The result is a familiar tension seen…
As regulators continue to assess the role of nicotine pouches within tobacco control frameworks, evidence on how these products are actually used over time remains limited. A recently published prospective study in Cureus helps address this gap by examining real-world patterns of nicotine pouch use across a ten-week period. The study is important not because…
Across Europe, policymakers continue to express concern that fragmented nicotine regulation is leaving young people exposed to risk. Recent commentary has pointed to uneven national rules governing nicotine pouches, vapes, and other novel products as evidence that current policy approaches are failing to protect youth. While these concerns are legitimate, fragmentation itself is not the…
A GINN response to “The war on snus” The Cyprus Mail article “The war on snus” highlights a regulatory paradox that is becoming increasingly familiar across Europe: nicotine pouches are treated as an urgent public-health threat, while combustible cigarettes remain legally available, widely sold, and socially embedded. From a GINN perspective, the issue is not…
Executive context Innovation in nicotine pouches has largely focused on formulation variables, nicotine strength, pH, buffering systems, flavours, and moisture content. These factors shape nicotine delivery and user perception and are central to regulatory assessment. However, a growing body of clinical, observational, and design-science evidence indicates that oral tolerability and mucosal outcomes are also strongly…
Regulation, clinical context, and evidence-based harm reduction Cigarette smoking continues to impose a disproportionate health burden in Appalachia, a region marked by persistently high smoking prevalence, elevated rates of cardiovascular disease and cancer, and long-standing socioeconomic barriers to cessation support. Despite decades of tobacco control efforts, combustible cigarette use remains entrenched in many Appalachian communities,…
A Deep Dive into the Future of Novel NicotineWe wish to share the latest episode of the Tobacco Asia / InterTabac podcast, where GINN’s Director Shem Baldeosingh joins Thomas Schmid for a wide-ranging conversation on the evolution of safer nicotine products and the global landscape. In this episode, Shem reflects on GINN’s journey since our…
Recent analysis published in The Lancet Public Health reinforces a long-standing but often overlooked reality in tobacco control: nicotine use is not a monolith, and public-health outcomes depend critically on how nicotine is delivered. Policies that fail to distinguish between combustible and non-combustible products risk undermining smoking reduction goals, particularly among adults who continue to…
Nicotine pouch performance is often discussed almost exclusively in terms of formulation. Nicotine concentration, pH, buffering systems, flavour chemistry, and moisture balance dominate both technical development and regulatory review. These elements are undeniably important. However, emerging evidence and user experience suggest that formulation alone does not fully explain how nicotine pouches are tolerated, used, or…
🇨🇳 China Confirms Nicotine Pouches Are Now Under the State Tobacco Monopoly China’s move to classify nicotine pouches within the state tobacco monopoly is now confirmed not only by specialist regulatory trackers but also by 2Firsts, which has published detailed reporting on the shift https://lnkd.in/gnx-jTTd The direction of travel is clear: a domestic market increasingly…
Youth “addiction” to nicotine pouches and other smoke-free nicotine products is increasingly invoked as a political shorthand, often without reference to how addiction is actually defined in modern clinical science. This matters, because the DSM-5 framework, the global reference standard for diagnosing substance-related disorders, does not define addiction by frequency of use alone, nor does…
Expectations around the European Union’s next revision of the Tobacco Products Directive (TPD3) have continued to shift, but a clearer picture is now emerging. Based on Commission planning documents, specialised monitoring services, and recent political signals, the most realistic scenario is that a formal Commission proposal will arrive in 2026, with any new regulatory obligations…
As nicotine pouches gain visibility in the United States and other markets, debate around their public-health role has intensified. Much of this discussion has been driven by concern over youth uptake and regulatory uncertainty. However, recent reporting in JAMA highlights a more nuanced picture, one in which several public-health experts recognise that nicotine pouches differ…
As nicotine pouch use expands globally, regulatory debate is increasingly framed as a choice between bans and permissive access. That framing is misleading. Evidence now points toward a more effective third path: risk-proportionate regulation that shapes product design to reduce harm while preserving adult access. Nicotine pouches are neither risk-free nor uniform. Their public-health impact…
Why excise policy matters for harm reduction in Europe Europe’s nicotine policy framework is entering a critical phase. Recent reporting on draft revisions to the EU Tobacco Excise Directive suggests that forthcoming tax proposals could significantly reshape the market for nicotine pouches, heated tobacco products, and other smoke-free alternatives. While excise taxation is a legitimate…
Recent media coverage of a report examining nicotine’s effects on the heart and blood vessels has renewed debate about cardiovascular risk and nicotine regulation. In response, experts contributing to the UK Science Media Centre (SMC) have provided important clarification that adds nuance often missing from public discussion. Their commentary reinforces a central principle in tobacco…
As nicotine markets continue to evolve, regulators are increasingly challenged to design policies that protect young people while also reflecting the growing body of evidence on relative risk among nicotine products. A new peer-reviewed study published in Nicotine & Tobacco Research adds important insight into how non-combustible nicotine products are used and perceived, and what…
Across many jurisdictions, governments have become structurally dependent on cigarette taxation as a stable source of public revenue. This dependence creates powerful fiscal and political incentives that can slow or complicate the transition away from combustible tobacco, even as public-health strategies increasingly emphasise harm reduction. In this environment, it is not coincidental that the companies…
Nicotine does have measurable effects on the cardiovascular system. That point is not in dispute. However, treating all nicotine products as equally harmful, regardless of whether they are smoked or smoke-free, is not supported by the balance of current evidence and risks undermining smoking cessation and broader public-health objectives. Recent commentary has renewed attention on…
Awareness and use of oral nicotine pouches are increasing across multiple countries, according to new peer-reviewed research published in BMJ Public Health. While this growth reflects changing nicotine markets and consumer behaviour, the findings also reveal a persistent challenge: greater awareness has not been matched by clear public understanding of relative health risk. This gap…
Ireland’s decision to prohibit the sale of nicotine pouches and other non-tobacco nicotine products to individuals under the age of 18 represents a proportionate and overdue step to protect children. Few would dispute the legitimacy of this measure. Preventing youth access to nicotine products is a core public-health objective and is consistent with both harm-reduction…
GINN is a business association representing small and medium-sized enterprises (SMEs) in the EU that are part of the safer nicotine products value chain. We comply fully with all EU transparency rules and requirements, and we have no connections—financial, material, or membership—to the multinational tobacco companies identified in recent reports. A new publication from STOP…
The STOP/Contre‑Feu narrative and the Tobacco Tactics profile both emphasise that some on the GINN Leadership Team previously worked for or with multinational tobacco companies and then infer a present‑day link or alignment with those firms’ lobbying objectives. That move is a textbook guilt‑by‑association tactic: past disclosed employment or sector experience is presented as sufficient to…
In 2023, Canada approved a tobacco-free oral nicotine pouch, marketed under the name Zonnic, as a nicotine replacement therapy for adult smokers. However, the regulatory framework governing its sale and distribution has created an unexpected contradiction: in some circumstances, it is now more difficult for adult smokers to obtain these potentially lower-risk products than to…
Public understanding of nicotine products increasingly depends on how science is communicated through mainstream media. Yet, misinformation and oversimplified reporting continue to influence how adults who smoke, regulators, and health professionals interpret the risks of non-combustible nicotine products. These narratives often emerge not from a lack of scientific evidence, but from how research is framed,…
COP11 has concluded, but the debate around nicotine regulation is far from settled. While delegates left Geneva without adopting aggressive new restrictions, the WHO’s long-standing hostility toward tobacco harm reduction remains firmly in place. The organization continues to frame non-combustible products, such as nicotine pouches, e-cigarettes, and heated tobacco, through the same lens as conventional…
I’m delighted to welcome MarĂa del Carmen Ordóñez LĂłpez as GINN’s Legal Advisor. MarĂa del Carmen brings more than two decades of strategic legal, compliance and governance experience across multinational corporations, start-ups and specialist advisory roles, and will be a pivotal voice in shaping our legal and regulatory work on novel nicotine policy and harm-reduction…
Saudi Arabia’s successful Public Health experiment Backed by the Public Investment Fund (PIF), Saudi company Badael has rapidly scaled its harm reduction initiative using its flagship DZRT tobacco-free nicotine pouch. Since its 2023 launch, the program has helped nearly 400,000 smokers move away from combustible tobacco, with 140,000 reportedly quitting nicotine altogether. This progress contributes…
A recent study published in JAMA Network Open provides important insights into the biological effects of nicotine pouches, adding much-needed clinical evidence to an area often dominated by speculation. The findings reaffirm a central message in tobacco harm reduction: while nicotine is addictive, the health risks associated with non-combustible nicotine products are dramatically lower than…
What a night! Great conversations, new connections, and plenty of collaboration with colleagues from across the nicotine pouch sector. 🗓️ 6:30–9:30 PM, Fri 14 November đź“Ť Central Stockholm We can’t wait to welcome you — come along, meet the community, and be part of the conversation. Want to join us? Drop us a line at…
Nicotine has been vilified for decades, often conflated with the devastating health effects of smoking. Yet modern medical research continues to show that nicotine itself is not the cause of smoking-related cancers or cardiovascular disease. Instead, it is the combustion of tobacco, the burning process that releases thousands of toxic chemicals, that drives most smoking-related…
Momentum is building in the United Kingdom toward a coherent and proportionate framework for regulating tobacco-free nicotine pouches. The Tobacco and Vapes Bill, currently progressing through Parliament, and the surrounding debates in both Houses have positioned the UK to establish a model that balances youth protection with adult harm reduction, consistent with NHS guidance and…
GINN has formally contributed to the European Commission’s Consultation on the revision of Council Directive 2011/64/EU, which governs excise duties on tobacco and related products. We welcome the inclusion of nicotine pouches in this revision, provided they are recognized as a distinct, clearly defined category separate from traditional tobacco products. A science-based approach is essential.…
A new peer-reviewed study published in PLOS One provides the most detailed snapshot yet of who uses nicotine pouches in the United Kingdom, what products they choose, and how often they use them. Conducted by researchers from King’s College London, University College London, and Brighton & Sussex Medical School, the study sheds light on a…
A new global modeling study by Dr. Derek Yach and Dr. Delon Human projects a future where more than 100 million lives could be saved by 2060, but only if the world embraces tobacco harm reduction (THR) as a central pillar of public health. The Lives Saved Report, released in October 2025 by Global Health…
Portugal has taken a decisive step toward formalising the regulation of nicotine pouches by creating a new excise tax category for these tobacco-free, smokeless products. Beginning in 2026, nicotine pouches will be subject to a tax rate of €0.065 per gram of net weight, effectively bringing them under the country’s broader tobacco and nicotine tax…
At a time when nicotine policy too often reflects fear rather than fact, the Nicotine Policy Hub, led by Dr. Jeffrey Willlett, has emerged as a thoughtful and evidence-based voice in the debate. The Hub’s new FAQ on nicotine regulation and harm reduction addresses persistent misconceptions and calls for a principled, science-driven approach that respects…
The growing visibility of nicotine pouches in gyms and fitness circles is sparking a new public conversation about where performance enhancement ends and risk begins. A recent GQ feature, “Why Men Are Using Nicotine Pouches for a Pre-Workout Boost,” captures a surprising trend: young adults, athletes, and casual gym-goers alike are turning to nicotine pouches…
The nicotine market is evolving faster than ever. Fueled by shifting consumer preferences, regulatory changes, and ongoing scientific advances, a new generation of smoke-free products is taking hold shape. As traditional tobacco declines, modern oral and inhalable formats are emerging as the next frontier for harm reduction, offering adult smokers safer, more convenient, and increasingly…
The global nicotine landscape is evolving, with oral nicotine pouches now preparing to enter markets long dominated by cigarettes and smokeless tobacco. The Swedish brand Loop, created by Another Snus Factory, has already established itself in Europe with modern flavors and strong consumer appeal. Its expansion into East Asia signals not only the growth of…
Recent reporting from Vejpkollen highlights a growing clash between Sweden and Brussels over proposed EU tax reforms that could dramatically reshape the nicotine pouch market. At the core of the dispute is a question of principle: should safer nicotine alternatives be taxed in the same way as cigarettes, or should taxation reflect their much lower…
A landmark study from Rutgers University offers the clearest national picture yet of nicotine pouch use in the United States, and the findings reinforce what harm reduction advocates have long argued: nicotine pouches are primarily being used by adults with prior tobacco experience, not by nicotine-naĂŻve individuals. A New National Estimate The Rutgers-led research, published…
Across Europe, governments are navigating one of the most complex public health challenges of our time: how to regulate emerging nicotine products while protecting youth, safeguarding consumers, and achieving long-term health goals. At the Global Institute for Novel Nicotine (GINN), we recognize that these concerns are legitimate. Our goal is not to challenge regulation, but…
For decades, smoking has remained one of the leading causes of preventable death worldwide. Despite countless awareness campaigns and cessation programs, millions of adults continue to smoke, often because nicotine addiction makes quitting extremely difficult. However, not all nicotine use carries the same level of risk, and understanding this distinction is essential to reducing harm.…
Recent reporting from Vejpkollen highlights a growing clash between Sweden and Brussels over proposed EU tax reforms that could dramatically reshape the nicotine pouch market. At the core of the dispute is a question of principle: should safer nicotine alternatives be taxed in the same way as cigarettes, or should taxation reflect their much lower…
As nicotine pouches continue to gain popularity as a smoke-free alternative for adult consumers, understanding their composition has become increasingly important. Unlike traditional tobacco products, nicotine pouches are tobacco-leaf free, relying on plant-based fibers and carefully selected ingredients to deliver nicotine effectively and consistently. Below is a breakdown of the six main ingredient categories typically…
The World Health Organization’s new Global Report on Tobacco Trends 2000–2024 paints a complex picture: while smoking rates continue to fall, one in five adults worldwide still uses tobacco. Between 2000 and 2024, the global number of tobacco users declined from 1.38 billion to 1.2 billion, an impressive 120 million fewer smokers since 2010. Yet,…
A new, independently conducted clinical study in Experimental and Clinical Psychopharmacology offers rare, high-quality evidence on how oral nicotine pouches perform for people who already use smokeless tobacco (SLT) and why nicotine content is the hinge on which substitution success turns. What the study asked and why it matters Alisha Eversole and colleagues at Virginia…
At InterTabac, GINN’s Phil Hudson sat down with Hannu Karvonen, representing Denssi nicotine pouches, a Finnish brand making waves in Europe and beyond. In their conversation, Karvonen shared how Denssi is balancing product innovation, global expansion, and new category development to meet changing consumer demands. From Finland to the World Denssi’s story begins in Finland,…
At InterTabac 2025, GINN’s Phil Hudson sat down with Shivam Bihani, co-founder of MYNT Nicotine Pouches, to discuss the company’s origins, market growth, and vision for the future of oral nicotine. The conversation revealed how MYNT, founded in 2020 in Gujarat, India, has quickly become a global player in tobacco harm reduction. From India to…
Policies meant to restrict access to nicotine pouches are turning out to be counterproductive, especially for workers, whose access to tobacco alternatives is already constrained by time, location, and economic pressures. In New Brunswick, Canada, a construction worker’s story powerfully illustrates the human cost when safer options are forced off convenience shelves and buried behind…
At the New Approaches Summit 2025, the conversation around oral pouches moved beyond nicotine. What began as a harm reduction innovation has now evolved into a platform with potential far beyond smoking alternatives. Oral pouches, once defined by snus and nicotine, are being reimagined as discreet, fast-acting vehicles for functional microdosing and even emerging therapeutic…
On the evening of 18 September 2025, the PouchXchange event at InterTabac – InterSupply in Dortmund brought together leading figures in the oral nicotine products sector. Organized as an industry gathering focused on compliance, commerce, and connection, the evening underscored how rapidly the nicotine pouch and next-gen oral market is evolving. GINN served as a…
Bangladesh is at a crossroads in its fight against tobacco. Despite decades of tobacco control policies, the country still faces some of the highest smoking and smokeless tobacco use rates in the world. More than 35 million adults consume tobacco in some form, and the toll on public health is devastating: over 161,000 people die…
In September 2025, France confirmed plans to ban the sale of nicotine pouches starting in 2026, a move hailed by anti-tobacco groups but criticized by harm reduction advocates as a serious setback for public health. The Ban and Its Rationale French authorities justified the ban as a measure to protect young people, pointing to rising…
The U.S. Food and Drug Administration (FDA) is accelerating its review of nicotine pouches, responding to mounting pressure from the White House to clarify the regulatory status of one of the fastest-growing categories in tobacco harm reduction. A Rapidly Expanding Market in Limbo Nicotine pouches, tobacco-free oral sachets delivering nicotine without combustion, have surged in…
GINN is delighted to welcome Asian Trade Media Group as both our newest member and media partner, an important step that strengthens our mission to build a global community grounded in science, compliance, and responsible growth. About Asian Trade Media Group As the team behind the widely respected AsianTrader.biz, Asian Trade Media Group brings decades…
The rapid growth of the oral nicotine pouch category has been one of the most significant shifts in global tobacco harm reduction over the past decade. From Sweden to the United States, millions of smokers are turning to pouches as a smoke-free, discreet, and lower-risk alternative to combustible tobacco. But as demand rises, so too…
The U.S. Food and Drug Administration (FDA) has announced strengthened requirements for child-resistant packaging (CRP) on nicotine products, underscoring the critical importance of safeguarding children while balancing access for adult smokers seeking reduced-risk alternatives. The decision comes amid rising concerns about accidental ingestion of nicotine pouches, e-liquids, and other smoke-free products. Although these products pose…
A new U.S. study is shedding light on how nicotine pouches may play a meaningful role in helping adults transition away from more harmful forms of tobacco. Research led by Dr. Cristine Delnevo, Distinguished Professor at the Rutgers School of Public Health, points to a clear pattern: the data reveal that pouch use is concentrated…
In July 2024, Canada banned the legal sale of nicotine pouches, restricting them to prescription-only access through Health Canada’s medical framework. At the time, regulators argued the move was necessary to protect youth from nicotine initiation. One year later, the results are clear and deeply troubling. Instead of reducing use, the prohibition has created the…
A coalition of 83 distinguished global authorities in public health, nicotine dependence, and tobacco control has issued a forceful open letter to the President of the European Commission and Commissioners. Their unified message: imposing steep new taxes on reduced-risk nicotine alternatives, such as e-cigarettes, heated tobacco, and nicotine pouches, would be a grave misstep. They…
Nicotine pouches, small tobacco-free sachets delivering nicotine orally, are emerging globally as a potential harm reduction tool. In Saudi Arabia, where smoking remains a major health burden and cultural factors shape patterns of tobacco use, new research provides the first comprehensive look at how nicotine pouches are being adopted, their perceived benefits, and the risks…
The European Union is preparing its most ambitious overhaul of tobacco and nicotine regulation in over a decade. With the simultaneous review of the Tobacco Products Directive (TPD), the Tobacco Advertising Directive (TAD), and a comprehensive recast of the Tobacco Excise Directive (TED), Brussels is signaling a shift that will affect consumers, governments, and the…
Contribution from Nancy Loucas The inaugural Asia Forum on Nicotine (AFN25), hosted by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) on 27 August, was a resounding success. The event drew together global experts, advocates, and consumers to champion evidence-based harm reduction strategies tailored to the Asia-Pacific region’s staggering 781 million tobacco users,…
Asia, the world’s largest consumer of combustible tobacco, is becoming a critical region in shaping the regulatory future of nicotine pouches and other smoke-free products. As governments across the continent respond to rising demand for safer nicotine alternatives, the picture that emerges is far from uniform. Regulations range from strict prohibitions and pharmaceutical-style oversight to…
Nicotine has long been misunderstood. Decades of public health messaging, though well-intentioned, have blurred the lines between nicotine itself and the deadly effects of combustible tobacco. A recent study published by the American Psychological Association underscores how deeply these misperceptions run, and why correcting them is essential for effective harm reduction. Misperceptions That Fuel Mistrust…
Despite decades of progress in tobacco control, smoking remains widespread across Europe. In countries like Germany, millions continue to smoke with little motivation to quit, leaving policymakers and scientists searching for pragmatic ways to reduce the toll of combustible tobacco. A recent article in Internal and Emergency Medicine by aerosol chemist Reinhard Niessner brings the…
Around the world, governments are rethinking how best to regulate tobacco and nicotine products in light of new science and innovation. Traditional tobacco control has long focused on restrictions and prohibitions, but the emergence of smoke-free alternatives, such as heated tobacco, e-cigarettes, and oral nicotine pouches, demands a more nuanced, evidence-based approach. The Need for…
Argentina is at a crossroads in its approach to tobacco control. Despite the country’s strong public health traditions and high burden of smoking-related disease, harm reduction strategies that could save lives remain absent from official policy. While other nations in Latin America and beyond are cautiously exploring safer nicotine alternatives, Argentina continues to rely on…
Australia now has one of the most restrictive nicotine control regimes in the developed world. Cigarettes face some of the highest taxes globally, while consumer nicotine vaping products are virtually banned. Intended to curb smoking, these policies have instead fuelled a thriving black market for tobacco and vapes, bringing with it organised crime, violence, and…
Despite decades of stigma, nicotine continues to reveal surprising roles in brain health through its interaction with nicotinic acetylcholine receptors (nAChRs). From improving attention to potentially slowing neurodegeneration, new science challenges outdated assumptions—and calls for a more nuanced conversation. Cognition and Mood: Nicotine’s Modulatory Role Nicotine’s primary mechanism of action in the brain is through…
Norway’s continued ban on nicotine pouches, in force since 2017, is one of the strictest policies in Europe. Despite mounting evidence that these products are significantly less harmful than cigarettes, they remain prohibited for sale and even private import. The intent, officials say, is to protect youth from nicotine initiation. Yet, many experts argue this…
From the betel-stained smiles of Southeast Asia to Scandinavia’s sleek pouch packaging, the rise of oral nicotine is not a one-size-fits-all story. Regional traditions, risk perceptions, and regulatory choices are shaping the path of harm reduction around the world, highlighting both promise and pitfalls. Southeast Asia: Tradition Meets Resistance Southeast Asia is home to more…
Public misunderstanding of nicotine remains a major obstacle to harm reduction, and the consequences are lethal. Despite decades of public health education about the dangers of smoking, many people still confuse nicotine with the primary causes of cancer and disease. But it’s not nicotine that causes lung cancer, emphysema, and heart disease, it’s the burning…
By Joseph Magero Kenya is on the brink of a pivotal decision in its tobacco control journey. The Tobacco Control (Amendment) Bill 2024, now under review by the Senate, is poised to introduce long-overdue regulation of new nicotine products, specifically nicotine pouches, e-cigarettes, and other smokeless alternatives that have until now existed in legal limbo.…
India’s tobacco landscape is uniquely complex and deeply rooted in social, regional, and cultural practices. This narrative review examines how tradition, yes, but also inequality and economic factors, shape tobacco use, and what that means for policy. Deep Roots: Tobacco as Tradition and Livelihood Tobacco in India isn’t new, it’s woven into rituals, social ceremonies,…
As the European Commission pushes forward on its most ambitious tobacco tax reform in over a decade, Portugal has stepped up as a strong opponent to key elements of the proposal. The sweeping reform, designed to align with the EU’s Beating Cancer Plan and introduce minimum tax levels on novel nicotine products like vapes and…
When nicotine pouches and vapes are confined to pharmacy sales, governments may intend to protect youth, but the effects can limit access, fuel illicit markets, and undermine harm reduction goals. Canada: Pharmacists Push Back on Expanding Retail Access In late July 2025, a national association of Canadian pharmacists firmly rejected proposals to expand nicotine pouch…
As global tobacco control architecture evolves, there’s growing concern that the WHO is reading its own treaty, the Framework Convention on Tobacco Control (FCTC), too narrowly. Ironically, while the FCTC explicitly includes harm reduction strategies in its mandate, WHO has sometimes dismissed reduced-risk nicotine products as part of industry rhetoric to be disregarded. This contradiction…
A shift from prohibition to regulation may soon reshape the French nicotine landscape. France is at a pivotal moment in determining the future of nicotine pouches, a tobacco-free oral product increasingly used by adult smokers as a lower-risk alternative to cigarettes. In 2024, the French government took a prohibitionist stance, notifying a draft decree that…
Nicotine has long been viewed through a narrow lens—often equated with smoking, addiction, and disease. But new research continues to challenge this oversimplification. As the global public health community confronts the rise of reduced-risk nicotine products like pouches, e-cigarettes, and heated tobacco, it is vital that we separate myth from evidence in shaping responsible policy.…
As the science around nicotine delivery evolves, so too must the platforms that publish and shape global understanding of its impacts. Springer’s Internal and Emergency Medicine journal has responded to this challenge with a bold move: the relaunch and expansion of its curated research collection under a new title—“Health Effects of E-Cigarettes, Heated Tobacco and…
While the debate around a unified term for non-combustible nicotine products continues across policy, science, and public health spheres, some of the most illuminating progress has come from within the community itself. In a recent exchange between Australian clinician Dr. Carolyn Beaumont and GINN Science & Standards Committee Chair Dr. Nveed Chaudhary, two leading voices…
By Shem Baldeosingh, Director, Global Institute for Novel Nicotine (GINN) In a global conversation about alternatives to smoking, terminology might seem secondary—but it’s not. Language shapes perception, policy, and access. For too long, inconsistent terms and acronyms have muddled understanding and hampered harm reduction progress. That’s why we’re opening the door to a wider community…
As we reach the midpoint of 2025, the nicotine sector is facing rapid change across categories, borders, and regulatory boundaries. In this strategic snapshot, we break down 3 key trends from the first half of the year and highlight 3 watchouts shaping the horizon. From market surges to global policy flashpoints, here’s what you need…
In response to: “Nicotine Pouch Poisonings Spike in Young Children“ A recent study published in Pediatrics has revealed a troubling rise in child nicotine poisonings in the U.S.—more than 134,000 cases involving children under 6 were reported to poison control centers between 2010 and 2023. Since 2020, exposures linked to nicotine pouches in particular have…
The European Commission’s approval of the 2028–2034 Multiannual Financial Framework signals a seismic shift in how tobacco taxation will function across the European Union. While touted as a modernization of fiscal policy, the measures raise critical questions about the future of harm reduction and whether safer alternatives to smoking will remain accessible and incentivized. 🔍…
Inspired by Dr. Carolyn Beaumont, an Australian clinician In the constantly evolving world of nicotine products, acronyms abound—NRT, NVP, ANDS, ENDS, e-cigarettes, HNB. Each of these terms captures a slice of the market, but none offer the unified, stigma-free language we need for effective global communication. That’s why the time has come to adopt one…
A leaked draft of the European Commission’s proposed Tobacco Tax Directive has sent shockwaves across public health and policy communities. Among its most controversial measures: an unprecedented tax hike on nicotine pouches—Sweden’s leading tool in its harm reduction strategy. The plan suggests increasing the tax on pouches in Sweden by over 650%, from 207 SEK/kg…
By Phil Hudson, Co-Founder & Associate Director @ GINN UK POLICY SHIFT: DISPOSABLE VAPES OUT, RESPONSIBILITY IN On 1 June 2025, the UK initiated a transformative public health and environmental move, the full-scale ban on disposable vapes.Targeting youth usage and the 5million+ weekly waste burden, the law now mandates sales of reusable devices only, with…
As nicotine pouches continue to gain global attention—praised by some as a safer alternative, and feared by others as a new public health risk—one claim is appearing with increasing frequency: “Pouches contain more nicotine than cigarettes.” While this may be technically true in terms of total nicotine content, it is fundamentally misleading when used to…
The Global State of Tobacco Harm Reduction 2024 (GSTHR) delivers one of the clearest pictures to date of where the world stands in its efforts to reduce smoking-related death and disease through safer nicotine products (SNPs). As the report reveals, the momentum for harm reduction is growing—but so too are the policy obstacles, misconceptions, and…
In 2025, Kenya became one of the first African countries to implement a fully integrated legal framework for regulating nicotine pouches. The government’s robust approach has aligned nicotine pouches with conventional tobacco products under national health law, closing critical loopholes and signaling a significant shift in the country’s public health policy. The newly gazetted rules,…
Nicotine pouches have emerged as a key innovation in the fight against smoking-related disease—offering a clean, discreet, and combustion-free option for adults seeking to quit cigarettes. Yet despite their potential, one group remains consistently underserved: low-income communities. These are the very populations most affected by smoking-related harm, and yet they are often the last to…
As organizations continue to refine their approaches to employee health, safety, and productivity, the rise of nicotine pouches presents a new consideration for workplace wellness strategies. Traditionally, smoking cessation support has centered on nicotine replacement therapy (NRT), education, and smoke-free policies. But today, a growing number of employers are beginning to acknowledge the role that…
Australia Queensland’s 2025 Amendment Regulation now classifies nicotine pouches as “illicit nicotine products,” creating new offences for their supply or possession in a business context and imposing penalty-infringement notices up to 200 penalty units for individuals and 1,000 for corporations. South Australia has banned nicotine pouches under its new illicit-products framework, treating them on par…
As the landscape of nicotine products evolves, much of the focus has rightly been placed on safety, efficacy, and regulation. Yet there is another equally important dimension that receives far less attention: dignity. For millions of adult smokers trying to quit, dignity—and the discretion that helps preserve it—can be a determining factor in whether they…
By Shem Baldeosingh, Director The Global Institute for Novel Nicotine (GINN), with the benefit of Joel Rubenstein’s vast expertise in the category, is working a comprehensive policy position on nicotine pouches and Nicotine Replacement Therapy (NRT), reaffirming our commitment to advancing harm reduction through innovative, science-backed alternatives to smoking. GINN strongly supports the availability of…
Spain is quickly becoming a focal point in the broader European debate over nicotine pouches. While EU institutions weigh broader harm reduction strategies, Spain has taken a more cautious—and in some cases, restrictive—approach to regulating these alternatives. GINN recently held a regional engagement in Spain to better understand the local regulatory landscape, meet with policymakers…
The World Health Organization (WHO) has renewed its call for a global ban on flavored nicotine products—a move that continues to raise concerns among harm reduction advocates, public health professionals, and adult consumers who rely on these products to quit smoking. At GINN, we recognize the critical need to protect youth. But we also believe…
A leaked internal report from the European Commission has raised urgent questions about the EU’s proposed overhaul of the Tobacco Excise Directive (TED). While the stated goals—reducing smoking and boosting revenue—may be well-intentioned, the Commission’s own analysis warns that sweeping tax hikes could have serious unintended consequences. From soaring excise increases to mounting black market…
By Joel Rubenstein, GINN Focal Point Nicotine Replacement Therapy (NRT) was born not out of global health ambition—but naval necessity. In the 1960s, Swedish submariners needed a smoke-free and spit-free way to consume nicotine underwater. The solution was nicotine gum—commissioned by the Swedish Navy and developed by local pharmaceutical companies. What started as a practical…
Sweden is poised to become the first country in the world to reach “smoke-free” status—defined as a smoking rate below 5%. According to newly released data, this achievement is not the product of prohibitionist measures but of pragmatic, evidence-based harm reduction policies, with nicotine pouches playing a central role—especially among women. The report Power in…
Several European Union Member States have formally called on the European Commission to introduce stricter regulation of vaping products and emerging nicotine alternatives. This coordinated initiative reflects growing concern among national governments about rising youth experimentation and the evolving nicotine product landscape. It also signals that the revision of the Tobacco Products Directive (TPD) and…
A newly published systematic review and network meta-analysis by La Rosa et al. (2025) offers valuable insights into the oral health effects of non-combustible nicotine products (NCNPs). As these products gain popularity as reduced-risk alternatives to smoking, understanding their broader health impact—including on oral health—is critical for clinicians, policymakers, and harm reduction advocates alike. The…
On January 7, 2025, the American Heart Association (AHA) released a comprehensive policy statement examining the cardiovascular health implications of smokeless oral nicotine products. Published in Circulation, the statement evaluates emerging products such as tobacco-free nicotine pouches, lozenges, gums, tablets, and gummies, many of which contain synthetic nicotine. This is the AHA’s first detailed update…
I’m proud to announce that Joel Rubenstein has joined GINN as our newest Focal Point. Joel brings more than 25 years of leadership in the health, wellness, and consumer healthcare sectors, with a proven track record across CPG, Rx, and OTC categories. His career spans US and Global marketing roles at Pfizer, Novartis and GlaxoSmithKline;…
Sweden is on track to become the first country in Europe to achieve smoke-free status, defined as having fewer than 5% of the adult population smoking. Behind this milestone is a powerful shift in consumer behavior—particularly among women—driven by the rising popularity of oral nicotine pouches. A recent press release from Smoke-Free Sweden highlights how…
Balancing Harm Reduction and Public Health in the Global Nicotine Dialogue As policymakers prepare for the WHO’s 11th Conference of the Parties (COP11) to the Framework Convention on Tobacco Control (FCTC), the question of whether to ban flavours in nicotine pouches and other reduced-risk products is front and center. While the WHO frames flavours as…
A new preprint study conducted by researchers at Emplicure provides promising evidence that bioceramic calcium sulfate-based nicotine pouches may offer faster and more efficient nicotine delivery than conventional cellulose-based formats. The findings, currently hosted on Research Square, could shape future innovations in nicotine pouch design and regulation. The study, titled Comparative study of calcium sulfate…
At the 2025 Global Forum on Nicotine in Warsaw, Emplicure Chief Clinical, Regulatory & Quality Officer Dr. Anna FranzĂ©n delivered a compelling presentation during the panel “Nicotine Pouches: What’s the Real Story?”. What Dr. FranzĂ©n Shared Dr. FranzĂ©n emphasised three critical pillars for nicotine pouches: Established safety of medicinal nicotine — highlighting how regulatory frameworks for nicotine…
I’m proud to announce that Joseph Magero will officially serve as GINN’s Focal Point for Sub-Saharan Africa. Joseph is a long-standing leader in the tobacco harm reduction (THR) movement—someone whose passion for public health and policy innovation has made a profound impact across Africa. His work spans public education, grassroots advocacy, and regional policy engagement,…
On Friday, GINN brought together leading voices from across the nicotine pouch industry for a high-impact networking event in Dubai—marking another key milestone in our global engagement efforts. Held one year after GINN’s inaugural launch in the same city, the Get Together welcomed GINN members, partners, and stakeholders for a dynamic day of collaboration, commercial…
On World No Tobacco Day 2025, the World Health Organization (WHO) and the UN Chronicle issued a strong call for governments to ban all flavours in tobacco and nicotine products, including cigarettes, e-cigarettes, and oral nicotine pouches. Their rationale is clear: flavours like bubblegum, cotton candy, and menthol are being used to attract youth and…
By Rohan Pike, GINN Focal Point on Anti-Illicit Trade As the UK’s Tobacco and Vapes Bill moves toward implementation, independent retailers are bracing for the fallout—not from enforcement, but from the lack of it. The Federation of Independent Retailers (The Fed) has sounded the alarm: small stores are already struggling to survive, and without proper…
Across Europe, the idea of a “smoke-free generation” is gaining traction among lawmakers. Proposed policies seek to ban the sale of tobacco products to anyone born after a certain year—effectively making smoking illegal for future generations. While these proposals may appear to be a bold public health move, they are increasingly coming under scrutiny for…
The Kingdom of Saudi Arabia is emerging as a pivotal region in the global harm reduction conversation, with momentum growing around novel nicotine products like oral pouches. At the recent Tobacco and Nicotine-Free Summit (TNFS), Dr. Christopher Russell, a behavioral scientist and harm reduction expert, outlined critical next steps for advancing nicotine policy in the…
The European Union stands at a crossroads. As lawmakers work to balance public health priorities with fiscal responsibilities, nicotine pouches have become a fascinating test case that could reshape how we think about harm reduction policy. Recent leaked documents from the European Commission reveal three distinct taxation approaches under consideration—each with profound implications for public…
The recent French ban on nicotine pouches has triggered a wave of backlash from harm reduction advocates, public health experts, and industry stakeholders. With punitive penalties and sweeping restrictions, the law represents one of the most stringent measures on nicotine alternatives seen in Europe. However, the story is still unfolding—and resistance is mounting. Industry Backlash…
By Robert Sidebottom, Chair of Regulatory & Compliance Committee, GINN & Managing Director, Arcus Compliance As regulators across Europe increase scrutiny of novel nicotine products, the need for clear, enforceable, and science-based packaging standards has never been greater. That’s why the Global Institute for Novel Nicotine (GINN) is endorsing the work of their member Arcus…
At the Global Institute for Novel Nicotine (GINN), we are committed to promoting science-based harm reduction, product responsibility, and ethical standards across the nicotine sector. While innovation and consumer choice are vital, they must always be balanced with a duty of care to public health, especially where youth appeal, misinformation, or excessive product strength are…
As novel nicotine pouches continue to gain traction across global markets, questions around their contents and safety remain top of mind for regulators, public health experts, and adult consumers. A comprehensive study published in the journal Drug and Chemical Toxicology helps answer one of the most pressing questions: What’s actually inside these tobacco-free pouches? 🧪…
🌅 *Join us in Dubai for an unforgettable evening!* 🌅 đź“Ť *The St. Regis Hotel, The Palm* đź“… *Friday, 20th June* đź•• 6-10pm 🎯 *GINN Get Together* We’re bringing together industry leaders and innovators for an exclusive evening of insights, networking, and celebration. *What’s in store:* ✨ Hear from our dynamic members *CAMO* and *CLEW*…
The Global Institute for Novel Nicotine (GINN) is honored to welcome Dr. Nveed Chaudhary as Chair of our Science and Standards Committee—a role central to guiding our mission for credible science, responsible innovation, and global public health advancement. Dr. Chaudhary brings more than 20 years of leadership at the intersection of science, regulation, and public…
France’s recent law banning nicotine pouches has become one of the most extreme regulatory actions taken against novel nicotine products in Europe. The ban, passed with limited parliamentary debate, criminalizes the sale, possession, and use of nicotine pouches, regardless of product formulation or age of the user. đź”´ Harsh Penalties Mirror Criminal Offenses According to…
Poland’s Ministry of Health is advancing legislation to ban flavoured nicotine pouches and disposable vape products, aiming to curb youth uptake and reduce nicotine experimentation among non-smokers. The draft bill, expected to pass given the ruling coalition’s parliamentary majority, would limit pouch flavours to tobacco-only options. A Broader European Trend Poland’s move aligns with a…
As novel nicotine products evolve, so too do the molecules behind them. One of the newest and most controversial is 6-methyl nicotine (6-MN)—a synthetic analog of nicotine that has now been detected in certain vaping devices and oral pouches. This compound, structurally similar to nicotine but chemically modified with a methyl group, may increase potency…
As the European nicotine landscape continues to evolve, Poland has become the latest member state to advance a national regulatory framework for nicotine pouches. The proposed law—now progressing through parliamentary stages—seeks to impose restrictions aimed at protecting youth while introducing much-needed clarity to a category that has, until now, operated in a regulatory grey area.…
A newly updated systematic review and meta-analysis published in F1000Research delivers one of the most comprehensive evaluations to date on the relative risks of nicotine delivery products. The findings are timely—and critical—for public health officials, regulators, and harm reduction advocates working to reshape tobacco policy for the 21st century. 🔍 Study Overview Researchers reviewed 123…
Reports have emerged that the European Commission may be preparing a significant tax increase on safer nicotine alternatives—including nicotine pouches and vaping products—by mid-2025. Though not yet confirmed, the leaked plans have stirred concern across industry and public health stakeholders, particularly as EU Tax Commissioner Wopke Hoekstra has recently been touring member state capitals seeking…
In the fast-evolving landscape of nicotine products, a silent threat is gaining momentum across the Middle East and North Africa (MENA): illicit nicotine pouches. While this product category is still relatively new to the region, its rapid growth—especially in Saudi Arabia—has created both success stories and serious challenges. A Promising Start, Followed by Illicit Surge…
Governments often turn to taxation as a lever to reduce public health risks, curb nicotine use, and generate revenue. In principle, that makes sense. But having seen Australia’s approach firsthand—as a former Australian Federal Police officer and founder of the Tobacco Strike Team—I can tell you this: when taxation goes too far, the consequences are…
The Growing Challenge of Illicit Nicotine Products As nicotine pouches gain traction in the UK as a smoke-free alternative, I believe we’re approaching a critical policy crossroads. The decisions made today will determine whether this market grows under a responsible, harm-reduction framework—or falls prey to the kind of illicit chaos I witnessed firsthand in Australia.…
The European Commission and several EU Member States have formally reviewed the draft Royal Decree submitted by Spain which proposes modifications to Spain’s national legislation governing the manufacturing, presentation, and marketing of tobacco products and related products. This draft decree was formally notified to the Commission on January 24, 2025, utilizing the procedure established by…
As Scotland deliberates the Tobacco and Vapes Bill, the discourse surrounding nicotine pouches has intensified. Professor Linda Bauld, a leading public health expert, has weighed in on the matter, offering insights into the relative harm of nicotine pouches compared to traditional cigarettes and emphasizing the need for responsible marketing practices. Understanding the Harm Profile Professor…
The Global Institute for Novel Nicotine (GINN) is proud to announce the appointment of Joe (Youssef) Sakr as Associate Director for the Middle East and North Africa (MENA). This exciting addition to GINN’s leadership team underscores our commitment to advancing harm reduction and nicotine innovation in a region that is beginning to embrace the potential…
Tim Phillips, Managing Director of TobaccoIntelligence, provided an overview with a frank assessment of the challenges—and opportunities—facing novel nicotine products under the EU’s evolving Tobacco Excise Directive (TED). The Tax Credibility Paradox Phillips underscored a unique irony: while taxation is often viewed as punitive, being taxed can actually confer regulatory legitimacy. “Without excise, regulators and…
As smoking rates remain stubbornly high across much of the Middle East and North Africa (MENA), health authorities and policymakers are exploring new ways to remember duce the region’s tobacco-related disease burden. One such possibility—oral nicotine pouches—is starting to enter the conversation. A recent article from Economy Middle East raises the question: Could these smoke-free…
A new study highlighted by Medical Xpress raises important questions about the role of flavors in nicotine pouches—and how they may influence the product’s appeal and addictiveness. As nicotine pouches gain traction as smoke-free alternatives, understanding these dynamics is essential for responsible public health policy. Here’s what the research shows, and why balanced regulation—not panic—is…
A major shift had been proposed for Canada’s nicotine market. The federal Conservative Party recently announced plans to end the restrictive pharmacy-only rule for nicotine pouches, aiming to open wider access to these smoke-free products for adult consumers. However, with the Liberals looking set to retain power in the upcoming federal election, the future of…
A recent article by Griffith University’s Blurred Minds Academy raises concerns about nicotine pouches, suggesting that they are being marketed in a way that appeals to minors. While protecting youth is critical, this narrative misrepresents the purpose and regulatory framework surrounding these products—and risks derailing an important harm reduction strategy for adults seeking safer alternatives…
A comprehensive new report titled “Saving Lives Like Sweden” compares the radically different public health outcomes between France and Sweden in tobacco use and harm reduction. Released by the Second Focused Study (SFS-2N) network, this study makes a powerful case for how adopting or rejecting safer nicotine alternatives directly impacts national health. A Tale of…
In a significant move towards tobacco harm reduction, Greece has emerged as the first European Union member state to permit scientifically substantiated claims regarding the reduced health risks of smoke-free alternatives. This progressive stance is part of Greece’s comprehensive National Action Plan Against Smoking, which emphasizes harm reduction alongside prevention, cessation support, and protection from…
April 21, 2025 The Global Institute for Novel Nicotine (GINN) issues this response to The Sunday Times article published on April 20, 2025, titled “How pouches of pure nicotine became a teenage craze.” As an organization committed to public health, harm reduction, and regulatory clarity, we believe the article fails to reflect the scientific evidence,…
The United Arab Emirates (UAE) is taking a groundbreaking step in redefining tobacco control by officially endorsing the use of less harmful nicotine products as part of its public health strategy. As reported by The National, this shift reflects a global momentum toward harm reduction—prioritizing science-based alternatives that help adult smokers transition away from combustible…
The closing session of EVO NXT Milan 2025 brought together a remarkable group of experts from across the novel nicotine industry to discuss one of the most pressing questions facing the category: how can innovation thrive under increasing regulatory scrutiny? Moderated by Robert Burton (Plxsur), the session featured insights from Geir Hammer (Den Norske Snusfabrikken),…
Reflexiones desde EVO NXT Milán 2025 | Moderado por MĂłnica Andrade Durante EVO NXT 2025 en Milán, GINN organizĂł una mesa redonda pionera en español que reuniĂł a voces clave del ámbito polĂtico, regulador y comercial para debatir sobre la evoluciĂłn del mercado de las bolsas de nicotina en España. Moderado por la Country Manager…
During EVO NXT 2025 in Milan, GINN caught up with Michiel Carmel of Clew for a candid and inspiring conversation about the evolving nicotine pouch industry—and why collective action is more essential than ever. Reflecting on the energy and camaraderie of the previous evening’s GINN Aperitivo, Michiel noted, “I thought last night was an amazing…
At EVO NXT 2025 in Milan, a standout session hosted by GINN brought together leading experts to decode one of the most complex challenges in the nicotine pouch industry: navigating the U.S. regulatory landscape. The panel, moderated by Dr. Sydney Hiller of Sanova, featured Rachel Schmidt (ALINC Consulting), Dr. Jessica Zdinak (AraC Science), and Chris…
At EVO NXT Milan, GINN caught up with Jacobo Truan Aguirre, Partner at EPPA and a seasoned regulatory strategist, to discuss what’s at stake for the nicotine pouch industry as European policies evolve. Known for his pragmatic yet principled approach, Truan didn’t hold back in his call for responsible standards, proactive industry engagement, and clear…
The Global Institute for Novel Nicotine (GINN) hosted a pivotal panel at EVO NXT Milan 2025, drawing together leading voices in regulation, public affairs, science, and consumer advocacy to tackle the complex interplay between innovation and regulation in the evolving nicotine landscape. The session, moderated by Wingle Group‘s Daria Votinova, featured industry experts Peter Beckett…
At a recent industry gathering, GINN sat down with Tautvydas Kviliunas, founder of Global Snus and the CAMO brand, to explore the evolution of nicotine pouches and the need for clearer communication across the category. Kviliunas, a leading voice in the European nicotine pouch space, shared his candid thoughts on consumer confusion, product formulation, responsible…
Insights from EVO NXT 2025, Milan The Global Institute for Novel Nicotine (GINN) hosted a powerful panel discussion at EVO NXT in Milan, bringing together experts from across science, compliance, and product development to address a crucial industry challenge: how to ensure quality and safety in novel nicotine products. Why a Code of Practice Matters…
Insights from Aron Byrne-Carter As the nicotine pouch category continues to expand, one key challenge remains front and center: helping consumers understand what they’re buying. In a recent conversation, Aron Byrne-Carter highlighted some of the biggest pain points facing both customers and retailers—and called for industry-wide action to make things clearer, simpler, and more consistent.…
Insights from the GINN Panel on Global Nicotine Industry Trends & Innovation At the Global Nicotine Industry Trends & Innovation panel during the GINN event in Milan, Monica Andrade De Orbe, GINN’s Country Manager for Spain, offered a compelling perspective on the evolving nicotine landscape in Southern Europe. With a focus on Spain, Andrade explored…
Governments around the world face a complex challenge: how to reduce smoking-related diseases while managing the regulation and taxation of nicotine products. A new briefing from the Global State of Tobacco Harm Reduction (GSTHR) makes a compelling case for how tax policy can support—not hinder—public health goals. Why Taxation Strategy Matters Historically, tobacco taxation has…
A confidential European Commission (EC) document, recently leaked, unveils a contentious proposal to impose substantial EU-wide taxes on nicotine pouches (NPs), also known as white snus. This initiative, driven by the Directorate-General for Taxation and Customs Union (DG TAXUD), has ignited significant apprehension among harm reduction advocates, economists, and industry stakeholders. citeturn0search0 Potential Economic and…
Australia’s approach to nicotine regulation has become a subject of intense debate, with critics arguing that its current framework has failed to distinguish between more and less harmful nicotine products. The sharp increases in tobacco taxes and a ban on consumer vaping have fueled an expansive black market, leading to criminal activity, regulatory gaps, and…
The United Arab Emirates (UAE) has recently finalized regulations impacting nicotine pouches, marking a significant milestone for the industry’s growth and regulatory clarity in the region. These regulations, outlined by the Emirates Authority for Standardization and Metrology (ESMA), set specific guidelines that manufacturers must follow to ensure compliance, consumer safety, and product integrity. Key Elements…
A Deep Dive into FDA Compliance, Scientific Strategy, and Behavioral Insights for Nicotine Pouch Success in the United States As the U.S. market continues to evolve, nicotine pouch manufacturers face an increasingly complex regulatory landscape. To help industry leaders prepare and strategize for market entry, GINN hosted a powerful masterclass, “Navigating the Introduction of Nicotine…
Recent research from Duke University School of Medicine has examined the role of artificial sweeteners in oral nicotine pouches and their potential effects on user behavior. The study, which analyzed popular nicotine pouch brands such as On!, Zyn, and Velo, found that these products contain significant amounts of sweeteners like acesulfame-K and sucralose. These additives…
Nicotine pouches have become an important tool in harm reduction, offering a smoke-free alternative to traditional cigarettes. Many veterans, who historically have higher smoking rates than the general population, have turned to these products as a way to transition away from combustible tobacco. However, recent legislative proposals in New York and other jurisdictions seek to…
Aligning Fiscal Policy with Tobacco Harm Reduction Goals The European Union is at a pivotal moment in shaping the future of tobacco and nicotine taxation. With discussions on revising Directive 2011/64/EU underway, policymakers have the opportunity to introduce a risk-proportionate taxation framework that aligns fiscal policy with public health objectives. This approach would create financial…
Taxation has long been a primary tool for tobacco control, designed to reduce smoking prevalence by increasing the cost of cigarettes. However, the emergence of novel nicotine products such as Electronic Nicotine Delivery Systems (ENDS), Heated Tobacco Products (HTPs), and nicotine pouches challenges traditional taxation models. Policymakers now face a crucial decision: Should all nicotine…
France has officially banned the sale of nicotine pouches, a move that underscores the escalating regulatory battle over alternative nicotine products within the European Union. The decision, announced by French Health Minister AurĂ©lien Rousseau, aligns with growing concerns from EU policymakers about the accessibility and potential youth appeal of nicotine pouches. However, this ban raises…
The European Union faces a defining moment in how it regulates tobacco-free nicotine products, particularly nicotine pouches. With some member states opting for outright bans while others seek a more balanced approach, the lack of a unified framework has created inconsistencies that threaten harm reduction efforts, consumer choice, and economic growth. As discussions on the…
The demand for nicotine pouches continues to grow across global markets, including Finland, where discussions about their regulation are gaining urgency. A recent article from Kauppa.fi highlights the pressing need for a responsible and supervised sales model to ensure that nicotine pouches remain accessible to adult consumers while preventing underage use and ensuring product safety.…
By Global Institute for Novel Nicotine (GINN) The South Australian Government’s ban on nicotine pouches, coupled with alarmist media narratives, distorts public understanding of these products. The recent article, “Everything You Need to Know About Nicotine Pouches,” presents nicotine pouches as a serious public health threat without properly assessing their risk profile compared to combustible…
The Global Institute for Novel Nicotine (GINN) has released its Member Code of Practice (CoP) to establish a comprehensive framework for the manufacturing and labelling of novel nicotine products. With regulatory landscapes evolving, GINN aims to ensure product safety, quality, and ethical practices, setting a standard for responsible nicotine innovation. A Framework for Responsible Manufacturing…
A BBC News investigation has shed light on the growing issue of illicit nicotine pouches in the UK, revealing the extent of unregulated sales and their impact on public health. The report highlights how some high-nicotine, unregulated pouches are being sold without proper safety labeling, age restrictions, or marketing controls. This raises concerns about youth…
The Global Institute for Novel Nicotine (GINN) is proud to champion oral health as a vital component of tobacco harm reduction. Through evidence-based research and actionable guidance, GINN is committed to reducing the burden of tobacco-related oral diseases and fostering healthier outcomes for communities worldwide. A Science-Driven Approach to Oral Health Tobacco use has long…
In Finland, nicotine pouches are subject to a specific taxation system that is tied to their strength. The tax is calculated based on the nicotine content per pouch, meaning that higher-strength pouches incur higher taxes. This system aims to discourage the use of high-nicotine products, promoting public health by making them less financially attractive. It’s…
The illicit nicotine pouch market is expanding rapidly, echoing the challenges faced during the early days of the unregulated e-vapor market. Without decisive action, this unregulated sector poses risks to public health, undermines harm reduction efforts, and creates an unfair playing field for compliant manufacturers. Understanding the root causes and addressing the issue with a…
A recent revelation from a leaked confidential document distributed by the European Commission’s consultant has sent ripples across the nicotine pouch industry. The document reportedly recommends a complete ban on nicotine pouches within the European Union, citing concerns over youth appeal, insufficient regulation, and perceived risks. This proposal has ignited significant debate among public health…
Norway is witnessing a profound shift in its approach to tobacco use, driven by consumer preferences and product innovation. The rise of snus, a smokeless, tobacco-containing product, has significantly reshaped the country’s public health landscape. This consumer-led movement demonstrates the transformative potential of harm reduction strategies and highlights the importance of providing safer alternatives for…
The rise of modern oral nicotine products, such as nicotine pouches and lozenges, represents a significant shift in the tobacco harm reduction landscape. These tobacco-free alternatives are increasingly being adopted by adult consumers seeking safer nicotine delivery options. However, with their rapid growth, global regulatory bodies face the challenge of establishing robust frameworks that balance…
We are thrilled to announce the appointment of Phil Hudson as the newest member of the GINN team. Phil will spearhead membership and outreach initiatives across the UK and European markets, bringing a wealth of experience and insight to our mission of advancing tobacco harm reduction and fostering innovation in the novel nicotine industry. A…
The U.S. Food and Drug Administration (FDA) has taken a landmark step in tobacco harm reduction by authorizing the marketing of 20 ZYN nicotine pouch products. This authorization, granted under the Premarket Tobacco Product Application (PMTA) process, establishes a clear regulatory pathway for nicotine pouches, reinforcing their role as a viable alternative for adult smokers…
The growing popularity of nicotine pouches as a smoke-free alternative has positioned them as a pivotal tool in tobacco harm reduction. However, their rapid market growth has also drawn increased regulatory scrutiny, particularly in the European Union (EU). As policymakers deliberate over the future of these products, the question arises: Could nicotine pouches face stricter…
The rise of nicotine pouch use in Great Britain, while modest, signals a pivotal shift in tobacco consumption trends. According to a new study published in Nicotine and Tobacco Research by Dr. Leonie Brose, Laura Bunce, and Hazel Cheeseman, nicotine pouch usage has reached 5.4%. However, only 1% of respondents reported current use, suggesting that…
1. Executive Summary Safer nicotine products (SNPs), such as nicotine pouches, lozenges, gums, dissolvables and other reduced-risk nicotine alternatives, should not be regulated in the same manner as combustible smoking tobacco products and nicotine vaping products because they– • are smokeless and do not pose the same relative health risks; • readily contribute to a…
As the global conversation on tobacco harm reduction evolves, regulatory frameworks for novel nicotine products are under scrutiny. Broughton Life Sciences Ltd., a leading consultancy in life sciences, recently submitted comprehensive recommendations to the UK Parliament, offering a roadmap for establishing safety, quality, and compliance standards for nicotine pouches and other reduced-risk alternatives. Key Recommendations…
As nicotine products evolve, public health policies must adapt to reflect scientific evidence and advance harm reduction goals. Central to this evolution is the idea of risk-proportionate taxation—a fiscal framework that aligns tax rates with the relative health risks of different nicotine products. This approach not only supports harm reduction but also incentivizes smokers to…
As the U.K. Parliament advances the Tobacco and Vapes Bill, a key feature is the introduction of a licensing scheme for retailers of nicotine pouches and alternative nicotine products. This initiative aims to regulate sales and storage, ensuring public health and safety. What Retailers Need to Know 🔹 Dual Licensing Requirement: Retailers must obtain both…
As the UK Tobacco and Vapes Bill advances in the House of Commons, GINN is preparing to contribute its insights. We believe the regulatory framework must balance innovation with public health while ensuring consumer safety. Here’s what we propose: 🔹 Market Access: Introduce a clear and transparent notification process for manufacturers, requiring detailed disclosures of…
As the European Union considers new tax measures under the proposed revision of the Tobacco Excise Directive (TED), the focus on nicotine pouches highlights the growing debate over their regulation and taxation. This burgeoning segment within the nicotine market holds promise for harm reduction, but significant taxation could undermine its potential to encourage smokers to…
Nicotine and tobacco products exist on a spectrum of risk, ranging from the highest to the lowest health impact. This risk continuum provides a valuable framework for understanding the varying health effects of these products on individuals and populations, empowering people to make more informed decisions for their health. The High-Risk End: Combustible Tobacco Products…
Greece has emerged as a leader in innovative strategies to reduce smoking-related harm, reflecting its commitment to improving public health. Over the past few years, the country has introduced comprehensive measures to combat smoking while embracing harm reduction as a pivotal part of its national strategy. The National Action Plan Against Smoking In November 2019,…
Nicotine, widely known for its association with tobacco products, is also recognized as an approved drug by health authorities such as the World Health Organization (WHO). In therapeutic contexts, nicotine plays a pivotal role in smoking cessation strategies, offering safer alternatives to combustible tobacco use. When delivered without the harmful effects of combustion, nicotine replacement…
At the inaugural session of GINN’s in-person panels, hosted by the Global Institute for Novel Nicotine (GINN), key industry leaders gathered to address the evolving landscape of the nicotine pouch industry. This landmark event was not only a platform for sharing insights but also for delineating the path forward amid changing regulatory environments and market…
The 2024 Global Anti-Smoking Index, as presented by “We Are Innovation” highlights significant advancements in tobacco control and harm reduction strategies across diverse regions. While certain nations shine as leaders in this space, others lag behind, underscoring the urgent need for equitable and effective global tobacco policies. European Nations Dominate the Top 20 European countries…
Recently, I came across an update on Sweden’s progress that included fascinating insights from Professor Fredrik Nystrom.His perspectives were nothing short of captivating, particularly his insights on the metabolic interplay between nicotine and coffee. Inspired by his talk, I have begun reading his book, which challenges many conventional health norms with a refreshing scientific rigor.…
Sweden has made remarkable progress in the fight against smoking, achieving what many thought impossible—bringing its smoking rate to an impressive 5.3%. By combining innovative strategies with traditional tobacco control measures, Sweden has set a powerful example for the world. At the heart of this success lies the “Triple-A Innovation,” focusing on three key aspects:…
Congratulations to Suely Castro and Federico N. Fernández, CEO of We Are Innovation for organizing such an impactful event! It was an incredible experience to attend Leading with Innovation: Sweden’s Path to Smoke-Free, where we celebrated Sweden’s remarkable journey toward a smoke-free future. 🌍🎉 A special shoutout to the keynote and panel speakers: Sweden has…
Nicotine pouches, small sachets placed between the gum and lip to release nicotine without tobacco, have become a focal point in global public health policies. Countries are grappling with their potential as smoking cessation tools versus concerns about health risks and youth appeal. New Zealand’s Evolving Stance In 2020, New Zealand’s Labour government banned the…
Recent global trends indicate a growing inclination among governments to impose bans or stringent regulations on nicotine pouches. While these measures are often driven by public health concerns, they may inadvertently overlook the potential of nicotine pouches as effective tools for smoking cessation and harm reduction. France’s Prohibition on Nicotine Pouches In October 2024, France…
Dated: 27 August 2024 The Global Institute for Novel Nicotine (GINN) has issued a strong warning against proposed government restrictions on vape products, emphasizing that such measures could hinder progress in helping smokers transition to less harmful alternatives. As a newly formed organization advocating for harm reduction, GINN is committed to advancing innovation and evidence-based…
